As at Nov 21, 2024, the ALKS stock has a PE ratio of 13.78. This is based on the current EPS of $2.01 and the stock price of $27.7 per share. An increase of 8% has been recorded in the P/E ratio compared to the average of 12.8 of the last 4 quarters.
The mean historical PE ratio of Alkermes over the last two years is 20.7. The current 13.78 PE ratio is 33% below the historical average. In the past two years, ALKS's PE ratio was at its highest in the Jun 2023 quarter at 51.31, with a price of $31.3 and an EPS of $0.61. The Mar 2024 quarter recorded the bottom point at 10.33, with a price of $27.07 and an EPS of $2.62.
Year | PE ratio | Change |
---|---|---|
2023 | 12.96 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
ALKS's current P/E ratio is lower than the 3, 5 and 10-year averages.
ALKS's PE ratio is lower than its peer stocks JNJ and AZN, but it is greater than NVS's. Alkermes is presently trading at a lower PE ratio (13.78) than its peer group average of 25.41.
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 12.03 | $207.63B |
ALKS Alkermes plc | 13.78 | $4.48B |
JNJ Johnson & Johnson | 25.79 | $374.39B |
AZN Astrazeneca plc | 30.75 | $199.21B |
PFE Pfizer Inc | 33.07 | $142.41B |
BMY Bristol Myers Squibb Co | N/A | $118.1B |
TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.35B |
The price to earnings ratio for ALKS stock as of Nov 21, 2024, stands at 13.78.
As an average over the last 3 years, ALKS stock has a PE ratio of 20.7.
As an average over the last 5 years, ALKS stock has a PE ratio of 20.7.
The highest quarterly PE ratio in the last two years has been 51.31 and it was in the Jun 2023 quarter.
ALKS's current price to earnings ratio is 33% below its 2-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Nov 21, 2024), Alkermes's stock price is $27.7. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.01. Therefore, Alkermes's P/E ratio for today is 13.78. PE RATIO(13.78) = STOCK PRICE($27.7) / TTM EPS($2.01)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.